Replacing Your Plasmid Construction by OriCiro™ Cell-Free Cloning System
- Type: Archived Webinar
- Level: Intermediate
- Duration: 1 hour
- PDHs: 0.00
In this webinar, Prof. Su’etsugu will talk about a novel tool kit for life science researchers, “OriCiro™ Cell-free Cloning System.” Many life science laboratories perform a conventional DNA cloning relying on E. coli which has been developed almost fifty years ago. The E. coli cloning is time-consuming, labor-intensive and has a limitation in efficiency and applicable size. Some DNA sequences are difficult to get a clone due to a cell-toxicity. How can you streamline your cloning workflow and widen the scope of your research?
The OriCiro™ Cell-free Cloning System consists of two enzymatic reactions, Assembly and Amplification. The Assembly reaction allows seamless assembly of multiple overlapping DNA fragments (>50 fragments) in a one-step reaction. The assembly products including assembly intermediates can be added directly to the Amplification reaction to amplify selectively your target circular DNA like a plasmid. After the reaction (within several hours), you’ll get a high concentration of the circular DNA (up to 100 ng/µL) with a great purity. Because a whole replication cycle of the E. coli chromosome is reconstituted in vitro using 26 purified proteins, the Amplification reaction has a unique feature in amplification fidelity (a single error/100-Mb/cycle) and amplification size (up to 50-kb in the commercial version). Any sequences including GC-rich or cell-toxic sequences are applicable.
You’ll learn the OriCiro™ Cell-free Cloning System as a powerful, rapid and easy tool-kit for your DNA construction/amplification in the era of synthetic biology.
Prof. Su'etsugu is a Chief Science Officer of OriCiro Genomics, Inc. He is also a Professor of Synthetic Biology at Rikkyo University located in Tokyo. He developed a novel synthetic biology technology for constructing and amplifying a large circular DNA such as a plasmid or genome by reconstituting a whole replication process of the E. coli chromosome in vitro (Su’etsugu et al., Nucleic Acids Res. 2017). On the basis of this technology, he co-founded the spin-off company, OriCiro Genomics, Inc in 2018.
He started his laboratory at Rikkyo University in 2013. His laboratory currently...Read more
|AIChE Graduate Student Members||Free|
|AIChE Undergraduate Student Members||Free|